image
Arbutus Biopharma Corporation ABUS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.64
0.276 %
$ 690 M
Market Cap
-8.47
P/E
CASH FLOW STATEMENT
-85.9 M OPERATING CASH FLOW
-143.06%
Growth Rates
1Year -143.06%
3Years -18.66%
5Years -4.82%
7Years -5.81%
10Years -28.99%
50.8 M INVESTING CASH FLOW
167.75%
Growth Rates
1Year 167.75%
3Years 75.50%
5Years 70.44%
7Years 14.06%
10Years 53.37%
30.6 M FINANCING CASH FLOW
-3.67%
Growth Rates
1Year -3.67%
3Years -29.31%
5Years -11.23%
7Years 13.49%
10Years -0.65%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Arbutus Biopharma Corporation
image
Net Income -72.8 M
Depreciation & Amortization 1.4 M
Capital Expenditures -1.01 M
Stock-Based Compensation 9.3 M
Change in Working Capital -18.2 M
Others -23.8 M
Free Cash Flow -86.9 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
OPERATING CASH FLOW
Net Income (72.8) (69.5) (76.2) (63.7) (153.7) (57.1) (84.4) (384.2) (61.1) (38.8) (14.1) 29.9 (9.7) (12.4) (9.3) (11.7) (2.6) 18.1 (8.1) (28.0) (34.1) (26.8) (14.0) (9.2) (8.2) (8.8)
Depreciation & Amortization 1.4 1.4 1.8 2.0 2.0 2.2 2.0 1.1 0.6 0.5 0.6 0.9 1.0 1.0 1.9 1.1 0.4 0.6 2.4 1.2 6.8 5.6 3.9 1.3 1.3 1.0
Deferred Income Tax 0 0 (8.2) (5.6) (12.7) (4.3) (24.3) (105.1) (16.2) (4.3) 18.1 K 3.9 9.8 (0.6) 0.1 0 0.4 0 0 0 0 0 0 0 0 0
Stock Based Compensation 9.3 7.2 6.4 6.2 6.8 6.2 15.1 39.2 22.1 3.3 0.9 1.0 0.6 0.7 0.3 0 0.4 0 0 0 0 0 0 0 0 0
Other Operating Activities (5.6) (3.8) 7.8 9.3 88.8 (10.7) 39.8 391.6 14.5 10.4 3.5 47.2 K (10.3) 0.7 0.3 (0.6) 0.2 (20.8) (5.8) 15.2 2.3 0.2 0.4 (0.5) 11.9 K 0
Change in Working Capital (18.2) 29.2 0.9 0.4 (2.2) (4.3) 3.1 (0.5) (14.6) 16.5 2.3 (2.4) 1.1 (0.5) 1.6 2.7 (1.6) (0.6) (3.1) 1.6 (2.0) 2.8 (0.2) 0.1 20 K 55.2 K
Cash From Operations (85.9) (35.4) (67.5) (51.4) (71.0) (67.9) (48.6) (57.9) (54.8) (12.4) (6.7) 33.3 (7.5) (11.2) (5.2) (8.5) (2.7) (2.6) (14.6) (10.0) (27.0) (18.2) (10.0) (8.4) (6.8) (7.7)
INVESTING CASH FLOW
Capital Expenditures (1.0) (0.5) (0.8) (0.2) (0.6) (1.1) (7.3) (4.0) (2.3) (1.1) (0.7) 14.9 K 58.4 K (0.8) (1.6) (1.0) (1.4) 94.9 K 45 K (7.1) (0.8) (2.0) (0.9) (0.2) (0.3) (3.2)
Other Items 51.8 (74.4) (11.9) (14.7) 28.9 (3.0) 35.1 (95.1) 10.0 (41.9) 0 2.5 K 0 0 5.5 4.2 1.23 K 14.1 K 0.4 2.9 17.8 4.9 (0.9) (13.0) (2.7) 10.4
Cash From Investing Activities 50.8 (74.9) (12.7) (14.9) 28.3 (4.1) 27.8 (99.1) 7.7 (43.0) (0.7) 12.4 K 58.4 K (0.8) 3.8 3.2 (1.4) 80.7 K 0.4 (4.2) 17.0 3.0 (1.9) (13.2) (3.0) 7.1
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 (12.0) 0 12.0 0 0 0 0 0 0 0 62.2 K 97.8 K 99.5 K (1.2) 49.6 K 0.5 (0.2) 95.5 K 38.5 K 0 0
Dividends Paid 0 0 (12.1) (12.1) (11.1) (10.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.8 11.5 14.7 12.6 30.0 77.7 49.3 0.6 1.7 4.2 0.7 0.7 10.8 K 0 0 24.7 K 5.2 (2.8) 0 0.2 0 9.7 5.1 0.158 0 0
Cash From Financing Activities 30.6 31.8 137.2 86.7 37.5 55.6 49.3 12.6 143.9 60.7 32.7 4.6 4.5 34.9 K 7.53 K 8.2 20.3 (2.9) (1.2) 0.8 20.6 9.8 35.6 13.1 19.9 48.9 K
CHANGE IN CASH
Net Change In Cash (4.5) (78.5) 57.0 20.5 (5.1) (17.4) 30.9 (143.4) 94.6 3.5 21.7 37.8 (3.1) (12.0) (1.7) 4.3 15.4 (5.6) (15.4) (13.4) 10.7 (5.4) 23.7 (8.5) 10.1 (0.5)
FREE CASH FLOW
Free Cash Flow (86.9) (35.9) (68.3) (51.7) (71.6) (69.0) (55.9) (61.9) (57.1) (13.5) (7.5) 33.3 (7.6) (12.1) (6.9) (9.5) (4.1) (2.7) (14.6) (17.1) (27.8) (20.1) (10.9) (8.6) (7.1) (10.9)